The size of the Electrophoresis Market in North America is predicted at USD 0.86 Billion in 2020 and will grow USD 1.1 billion by 2025. This market is growing at a CAGR of 5.05% from 2020 to 2025. North America is the leading region in the global market. The growing number of cancer cases and increasing usage of capillary electrophoresis with mass spectroscopy primarily drive the market growth of this region.
Electrophoresis is used as immune-electrophoresis, which can be used to detect specific proteins like immunoglobulins, which act as antibodies. These are part of the body’s immune system and protect from foreign proteins. Analyzing these antibodies helps design new therapies to treat these threats and provides insight into conditions like allergies and autoimmune disorders. Electrophoresis is the motion of dispersed particles relative to a fluid influenced under a uniform electric field applied spatially.
The primary factors accounted for the growth of the market are rising to fund electrophoresis techniques, increasing incidences of chronic diseases, cancer and genetic disorders, growing focus on next-generation sequencing (NGS). The growing number of industry-academia research collaborations and increasing funding for research on genomic and proteomic techniques will also support the growth of the market.
On the other hand, electrophoresis techniques are time-consuming operations and offer limited sample analysis, and the presence of alternative technologies to electrophoresis may curb the growth of the market.
This research report segmented and sub-segmented the North America Electrophoresis Market into the following categories:
Based on the region, The United States is leading the North American market while Canada is second. The growing focus of stakeholders on research projects involving proteins, associated biomolecules, and genes has helped the U.S. dominate the market. The United States is also expected to grow the fastest due to increasing research funding, growing proteomics and genomics techniques and rising adoption of advanced electrophoresis techniques.
The electrophoresis market of Canada was in second place in the North American Electrophoresis market in 2019. Factors such as increasing occurrence rate of cancer, infectious diseases, and genetic disorders propelling the market. However, the installation and maintenance of the equipment are so expensive, and variations in economic strategies within a short period restrict the market growth in this region.
Promising Companies dominating this North America Electrophoresis Market Profiled in the Report are Bio-Rad Laboratories, GE Healthcare, Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies, Merck Millipore, PerkinElmer, QIAGEN N.V., Lonza Group Ltd., Shimadzu Corporation, Harvard Bioscience, Serbia Group, and C.B.S. Scientific Company.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Gel Electrophoresis
5.1.2.1 Gel Electrophoresis by Instrument type
5.1.2.1.1 Horizontal Gel Electrophoresis
5.1.2.1.2 Vertical Gel Electrophoresis
5.1.2.1.2.1 1d Gel Electrophoresis
5.1.2.1.2.2 2d Gel Electrophoresis
5.1.2.2 Gel Electrophoresis by Gel type
5.1.2.2.1 Agarose Gel Electrophoresis
5.1.2.2.2 Polyacrylamide Gel Electrophoresis
5.1.3 Capillary Electrophoresis
5.1.3.1 Capillary Zone Electrophoresis
5.1.3.2 Capillary Gel Electrophoresis
5.1.3.3 Capillary Isoelectric Focusing
5.1.3.4 Micellar Electrokinetic Capillary Chromatography
5.1.3.5 Capillary Isotachophoresis
5.1.3.6 Capillary Electrochromatography
5.1.4 Geldoc
5.1.5 Imaging
5.1.6 Y-o-Y Growth Analysis, By Product
5.1.7 Market Attractiveness Analysis, By Product
5.1.8 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Diagnostics Development
5.2.3 Research and Development
5.2.4 Quality Control
5.2.5 Other Applications
5.2.6 Y-o-Y Growth Analysis, By Application
5.2.7 Market Attractiveness Analysis, By Application
5.2.8 Market Share Analysis, By Application
5.3 End Users
5.3.1 Introduction
5.3.2 Academic and Research Institutes
5.3.3 Pharmaceutical & Biotechnology Companies
5.3.4 Hospitals & Diagnostic Centers
5.3.5 Others
5.3.6 Y-o-Y Growth Analysis, By End Users
5.3.7 Market Attractiveness Analysis, By End Users
5.3.8 Market Share Analysis, By End Users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.1.5.4 By End User
6.2 United States
6.3 Canada
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Bio-Rad Laboratories
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 GE Healthcare
8.3 Thermo Fisher Scientific Inc
8.4 Danaher Corporation
8.5 Agilent Technologies
8.6 Merck Millipore
8.7 PerkinElmer
8.8 QIAGEN N.V.
8.9 Lonza Group Ltd
8.10 Shimadzu Corporation
9.Competitive Landscape
Related Reports
